Want to see APVO full AI Analyst Report?
Aptevo Therapeutics (APVO) Income Statement
Aptevo Therapeutics Income Statement
Last quarter (Q2 2026), Aptevo Therapeutics's total revenue was $0.00. In Q2, Aptevo Therapeutics's net income was $-6.36M. See Aptevo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 3.11M | $ 12.29M | |
| $ -240.00K | $ -352.00K | $ 0.00 | $ 3.11M | $ 12.29M | |
| $ 26.07M | $ 24.25M | $ 28.88M | $ 31.75M | $ 33.69M | |
| Depreciation and Amortization | $ 240.00K | $ 352.00K | $ 567.00K | $ 901.00K | $ 1.14M |
| $ -25.73M | $ -23.78M | $ -18.08M | $ 7.92M | $ -28.26M | |
| $ -26.31M | $ -24.60M | $ -28.88M | $ -28.64M | $ -21.40M | |
| $ 345.00K | $ 472.00K | $ 10.23M | $ 35.66M | $ -8.01M | |
| $ -25.97M | $ -24.13M | $ -18.65M | $ 7.01M | $ -29.41M | |
| $ -25.97M | $ -24.13M | $ -17.41M | $ 8.03M | $ -28.46M | |
| Per Share Metrics | |||||
| Basic EPS | $ -87.27 | $ -31458.00 | $ -834044.00 | $ 922390.00 | $ -3557646.00 |
| Diluted EPS | $ -87.27 | $ -31458.00 | $ -834044.00 | $ 921915.00 | $ -3557646.00 |
| Weighted Average Shares Outstanding | 3.15K | 767 | 21 | ― | ― |
| Weighted Average Shares Outstanding (Diluted) | 3.15K | 767 | 21 | ― | ― |
Currency in USD
